A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

Lung adenocarcinoma is one of the most malignant diseases worldwide. The immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) have changed the paradigm of lung cancer treatment; however, there are still patients who are resistant. F...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Cell Dev Biol
Main Authors: Zheng, Yujia, Tian, He, Zhou, Zheng, Xiao, Chu, Liu, Hengchang, Liu, Yu, Wang, Liyu, Fan, Tao, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Gengshu, Li, Chunxiang, He, Jie
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Cell and Developmental Biology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017122/
https://ncbi.nlm.nih.gov/pubmed/33816503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.651406
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares